CNS interleukin-3 (IL-3) expression and neurological syndrome in antisense-IL-3 transgenic mice

Journal of Neuropathology and Experimental Neurology

Volumn 58, Issue 5, 1999, Pages 480-488

  Sugita, Yukihiro ^a   Zhao, Boyu ^b   Shankar, Pragyna ^c   Dunbar, Cynthia E ^d   Doren, Sandra ^d   Young, Howard A ^e   Schwartz, Joan P ^d  

^a JUNTENDO UNIVERSITY   (Japan)

^b CNS/Drug Discovery   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Antisense mRNA; Astrocytes; Interleukin 3; Microglia; Neuronal death; Reactive gliosis; Transgenic mice

Indexed keywords

COMPLEMENTARY RNA; CYTOKINE; INTERLEUKIN 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CORTEX; CONTROLLED STUDY; CYTOKINE RELEASE; GLIOSIS; HISTOPATHOLOGY; MICROGLIA; MOUSE; NERVE CELL NECROSIS; NEUROLOGIC DISEASE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; RNA ANALYSIS; TRANSGENIC MOUSE;

EID: 0032955737     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199905000-00007     Document Type: Article

References (31)

1. Ihle JN. Interleukin-3. In: Born GVR, Cuatrecasas P, Herken H, eds. Handbook exp pharmacology. Berlin: Springer 1990;95:541-75
2. Schrader JW. Interleukin-3. In: Thomson A, ed. The cytokine handbook. Academic Press. 1991:103-18
3. Campbell IL, Chiang C-S. Cytokine involvement in central nervous system disease: Implications from transgenic mice. Ann New York Acad Sci 1995;771:301-12
4. Rothwell NJ, Hopkins SJ. Cytokines and the nervous system II: Actions and mechanisms of action. Trends Neurosci 1995;18:130-36
5. Spleiss O, Appel K, Boddeke HWGM, Berger M, Gebicke-Haerter PJ. Molecular biology of microglia cytokine and chemokine receptors and microglial activation. Life Sci 1998;62:1707-10
6. Frei K, Bodmer S, Schwerdel C, Fontana A. Astrocyte-derived interleukin 3 as a growth factor for microglia cells and peritoneal macrophages. J Immunol 1986;137:3521-27
7. Giulian D, Ingeman, JE. Colony-stimulating factors as promoters of ameboid microglia. J Neurosci 1988;8:4707-17
8. Htain W-W, Leong S-K, Ling E-A. Effects of interleukin-3 injection on supraventricular amoeboid microglial cells in neonatal BALB/c and athymic mice. Neurosci Lett 1998;251:133-36
9. Suzumura A, Sawada M, Yamamoto H, Marunouchi T. Effects of colony stimulating factors on isolated microglia in vitro. J Neuroimmunol 1990;30:111-20
10. Kamegai M, Niijima K, Kunishita T et al. Interleukin 3 as a tropic factor for central cholinergic neurons in vitro and in vivo. Neuron 1990;4:429-36
11. Mazzoni IE, Kenigsberg RL. Microglia from the developing rat medial septal area can affect cholinergic and GABAergic neuronal differentiation in vitro. Neurosci 1997;76:147-57
12. Moroni SC, Rossi A. Enhanced survival and differentiation in vitro of different neuronal populations by some interleukins. Int J Devel Neurosci 1995;13:41-49
13. Cockayne DA, Bodine DM, Cline A, Nienhuis AW, Dunbar CE. Transgenic mice expressing antisense interleukin-3 RNA develop a B-cell lymphoproliferative syndrome or neurologic dysfunction. Blood 1994;84:2699-710
14. Schwartz JP, Wilson DJ. Preparation and characterization of type 1 astrocytes culltured from adult rat cerebral cortex, cerebellum and striatum. Glia 1992;5:75-80
15. Gebicke-Haerter PJ, Van Calker D, Nörenberg W, Illes P. Molecular mechanisms of microglial activation. A. Implications for regeneration and neurodegenerative diseases. Neurochem Int 1996;29:1-12
16. Frei K, Bodmer S, Schwerdel C, Fontana A. Astrocytes of the brain synthesize interleukin 3-like factors. J Immunol 1985;135:4044-47
17. Chiang C-S, Stalder A, Samimi A, Campbell, IL. Reactive gliosis as a consequence of interleukin-6 expression in the brain: Studies in transgenic mice. Dev Neurosci 1994; 16:212-21
18. Gebicke-Haerter PJ, Appel K, Taylor GD et al. Rat microglial interleukin-3. J Neuroimmunol 1994;50:203-14
19. Kittler ELW, McGrath H, Temeles D, Grittenden RB, Kister VK, Quesenberry PJ. Biologic significance of constitutive and subliminal growth factor production by bone marrow stroma. Blood 1992;79:3168-78
20. Wesselingh SL, Gough NM, Finlay-Jones JJ, McDonald PJ. Detection of cytokine mRNA in astrocyte cultures using the polymerase chain reaction. Lymphokine Res 1990;9:177-85
21. Glabinski AR, Balasingam V, Tani M et al. Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain. J Immunol 1996;156:4363-68
22. Kim JS, Gautam SC, Chopp M et al. Expression of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 after focal cerebral ischemia in the rat. J Neuroimmunol 1995;56: 127-34
23. Wahl SM, Allen JB, McCartney-Francis N et al. Macrophage-and astrocyte-derived transforming growth factor beta as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome. J Exp Med 1991;173:981-91
24. Chiang C-S, Powell HC, Gold LH, Samimi A, Campbell IL. Macrophage/microglial-mediated primary demyelination and motor disease induced by the central nervous sytem production of interleukin-3 in transgenic mice. J Clin Invest 1996;97:1512-24
25. Giulian D, Corpuz M, Chapman S, Mansouri M, Robertson C. Reactive mononuclear phagocytes release neurotoxins after ischemic and traumatic injury to the central nervous system. J Neurosci Res 1993;36:681-93
26. Araujo DM, Lapchak PA. Induction of immune system mediators in the hippocampal formation in Alzheimer's and Parkinson's diseases: Selective effects on specific interleukins and interleukin receptors. Neurosci 1994;61:745-54
27. Böttinger EP, Letterio JJ, Roberts AB. Biology of TGF-β in knockout and transgenic mouse models. Kidney Int 1997;51:1355-60
28. Corbin JG, Kelly D, Rath EM, Baerwald KD, Suzuki K, Popko B. Targeted CNS expression of interferon-γ in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development. Mol Cell Neurosci 1996;7:354-70
29. Keffer J, Probert L, Cazlaris H et al. Transgenic mice expressing human tumour necrosis factor: A predictive genetic model of arthritis. EMBO J 1991;10:4025-31
30. Woodroofe C, Mueller W, Ruether U. Long-term consequences of interleukin-6 overexpression in transgenic mice. DNA Cell Biol 1992;11:587-92
31. Michaelson MD, Bieri PL, Mehler MF et al. CSF-1 deficiency in mice results in abnormal brain development. Development 1996;122:2661-72